Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Галина Дмитриевна Фадеенко, Виктория Михайловна Каменир, Евгений Дмитриевич АндросовfiledCriticalГалина Дмитриевна Фадеенко
Priority to UAU201103248UpriorityCriticalpatent/UA64830U/en
Publication of UA64830UpublicationCriticalpatent/UA64830U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
A method for treatment of patients with gastroesophageal reflux disease combined with chronic obstructive lung disease comprises the administration on the background of standard therapy of "Kontrolok®" inhibitor of proton pump preparation and selective inducible synthase inhibitor (i - NOS) “Vita-melatonine” melatonine preparation.
UAU201103248U2011-03-212011-03-21method for treatment of patients with gastroesophageal reflux disease combined with chronic obstructive lung disease
UA64830U
(en)
Государственное бюджетное образовательное учреждение высшего профессионального образования "Северо-Осетинская государственная медицинская академия" Минздравсоцразвития Российской Федерации
Method of treating patients with gastroesophageal reflux disease
Государственное бюджетное образовательное учреждение высшего профессионального образования "Северо-Осетинская государственная медицинская академия" Минздравсоцразвития Российской Федерации
Method of treating patients with gastroesophageal reflux disease
Anti-adrenomedullin (adm) antibpdy or anti-adm antibody fragment of anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic of acute disease or acute condition
((E) -N- {3- [1- (8-ФТОР-11H-10-ОКСА-1-AZA-DIBENZO [A, D] CYCLOHEPTEN-5-ILIDEN) PROPYL] PHENYL METHANESULFONAMID) AS A MODULATOR GLUCOCORTICOIDS FOR THE TREATMENT OF RHEUMATISM
method for TREATMENT of patients with lungs chronic obstructive disease in combination with non-alcoholic stetatohepatitis on background of lungs tuberculosis